Claus Torp Jensen - Mar 1, 2022 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
Chief Innovation Officer
Signature
/s/ Adam C. Vandervoort, attorney-in-fact
Stock symbol
TDOC
Transactions as of
Mar 1, 2022
Transactions value $
$0
Form type
4
Date filed
3/2/2022, 03:22 PM
Next filing
May 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Award $0 +33.7K $0.00 33.7K Mar 1, 2022 Common Stock 33.7K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F2 One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.